Honestly I like to see at least x 1.5 of what Bristol Myers paid for Karuna for their schizophrenia drug in 2024. I could be wrong but $14 bill was paid for the successful ph2. Then not long after I read a title of the article saying their trial failed. I thought what a bummer for the buyer back then. Just now I learned that they got approval in Sep 2024. Is this mean they rejected initially by FDA and approved shortly after in a few months in 2024? $14 bill x 1.5 will be x 80 of our current MC. I guess it depends on before or after an 'approval'. I can dream, right? : )
Market Data 
Markets 
AI
